NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080224987

Registered date:16/12/2019

Basic Information

Recruitment status completed
Health condition(s) or Problem(s) studied
Date of first enrollment01/08/2019
Target sample size750
Countries of recruitmentJapan,North America,Europe,Oceania
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : INN of investigational material : brolucizumab Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Aflibercept Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcomeefficacy
Secondary Outcomesafety efficacy

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteria
Exclude criteria

Related Information

Contact

Public contact
Name
Address
Telephone +81-120-003-293
E-mail
Affiliation
Scientific contact
Name
Address
Telephone +81-120-003-293
E-mail
Affiliation